U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 233

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr2:144657717-159178136
GRCh38:
Chr2:143900149-158321624
See casesPathogenic
(Jul 30, 2009)
no assertion criteria provided
2.
GRCh37:
Chr2:148009516-158712890
GRCh38:
Chr2:147251948-157856378
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
3.
GRCh37:
Chr2:149674855-164061133
GRCh38:
Chr2:148917286-163204623
ACVR1, ACVR1C, ARL5A, ARL6IP6, BAZ2B, BAZ2B-AS1, CACNB4, CCDC148, CCDC148-AS1, CD302, CYTIP, DAPL1, DPP4, DPP4-DT, ERMN, FAP, FLJ46875, FMNL2, GALNT13, GALNT13-AS1, GALNT5, GCA, GCG, GPD2, IFIH1, ITGB6, KCNH7, KCNH7-AS1, KCNJ3, KIF5C, LINC01806, LINC01817, LINC01818, LINC01876, LINC01920, LINC01931, LINC02478, LINC02612, LOC101929319, LOC101929532, LOC108175345, LOC108281133, LOC108348024, LOC110120673, LOC110120674, LOC110120675, LOC110120676, LOC110120708, LOC110120710, LOC110120736, LOC110121086, LOC110121120, LOC110121242, LOC111556122, LOC112806054, LOC112806055, LOC112806056, LOC114827830, LOC115945200, LOC117152610, LOC117152611, LOC120961787, LOC120977009, LOC120977010, LOC120977011, LOC120977012, LOC121725105, LOC122819166, LOC122819167, LOC122847293, LOC122847294, LOC122847295, LOC122847296, LOC122847297, LOC122847298, LOC122847299, LOC122847300, LOC122847301, LOC122847302, LOC122847303, LOC122847304, LOC122847305, LOC122847306, LOC122847307, LOC126806368, LOC126806369, LOC126806370, LOC126806371, LOC126806372, LOC126806373, LOC126806374, LOC126806375, LOC126806376, LOC126806377, LOC126806378, LOC126806379, LOC126806380, LOC126806381, LOC126806382, LOC126806383, LOC126806384, LOC126806385, LOC126806386, LOC126806387, LOC126806388, LOC126806389, LOC126806390, LOC126806391, LOC126806392, LOC126806393, LY75, LY75-CD302, LYPD6, LYPD6B, MARCHF7, MIR4773-1, MIR4773-2, MIR4785, MIR6888, MIR9899, MMADHC, MMADHC-DT, NEB, NMI, NR4A2, PKP4, PKP4-AS1, PLA2R1, PRPF40A, PSMD14, PSMD14-DT, RBM43, RBMS1, RIF1, RND3, RPRM, SLC4A10, STAM2, TANC1, TANK, TANK-AS1, TBR1, TNFAIP6, TRA-CGC3-1, TRG-GCC2-2, UPP2, WDSUB1
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
4.
GRCh37:
Chr2:152788858-160276245
GRCh38:
Chr2:151932344-159419734
See casesPathogenic
(Dec 22, 2010)
no assertion criteria provided
5.
GRCh37:
Chr2:154466227-159041637
GRCh38:
Chr2:153609714-158185125
See casesPathogenic
(Sep 21, 2012)
no assertion criteria provided
6.
GRCh37:
Chr2:155150555-176854100
GRCh38:
Chr2:154294042-175989372
SLC25A12, SLC38A11, SPC25, SLC4A10, SNORA70F, SNORD3K, SP3, SP5, SP9, SSB, STK39, TANC1, TANK, TANK-AS1, TBR1, TLK1, TRA-CGC3-1, TRG-GCC2-2, TTC21B, TTC21B-AS1, UBR3, UPP2, WDSUB1, WIPF1, XIRP2, XIRP2-AS1, ABCB11, ACVR1, ACVR1C, ATF2, ATP5MC3, B3GALT1, B3GALT1-AS1, BAZ2B, BAZ2B-AS1, BBS5, CCDC148, CCDC148-AS1, CD302, CDCA7, CERS6, CERS6-AS1, CFAP210, CHN1, CHRNA1, CIR1, COBLL1, CSRNP3, CYBRD1, CYTIP, DAPL1, DCAF17, DHRS9, DLX1, DLX2, DLX2-DT, DPP4, DPP4-DT, DYNC1I2, ERICH2, ERICH2-DT, ERMN, FAP, FASTKD1, FIGN, FLJ46875, G6PC2, GAD1, GALNT13, GALNT13-AS1, GALNT3, GALNT5, GCA, GCG, GORASP2, GPD2, GPR155, GPR155-DT, GRB14, HAT1, IFIH1, ITGA6, ITGA6-AS1, ITGB6, KCNH7, KCNH7-AS1, KCNJ3, KLHL23, KLHL41, LINC01124, LINC01305, LINC01806, LINC01876, LINC01960, LINC02478, LNPK, LOC100506124, LOC101929532, LOC101929633, LOC102724058, LOC108175345, LOC108281133, LOC110120601, LOC110120624, LOC110120625, LOC110120626, LOC110120673, LOC110120674, LOC110120675, LOC110120676, LOC110120677, LOC110120678, LOC110120701, LOC110120708, LOC110120710, LOC110120725, LOC110120730, LOC110120736, LOC110120790, LOC110120809, LOC110121120, LOC110121216, LOC110121242, LOC111413009, LOC111556122, LOC112806056, LOC112806057, LOC112806058, LOC112806059, LOC112806060, LOC114827830, LOC115945201, LOC117152610, LOC117152611, LOC120977010, LOC120977011, LOC120977012, LOC120977013, LOC120977014, LOC120977015, LOC121725105, LOC121725106, LOC121725107, LOC122847298, LOC122847299, LOC122847300, LOC122847301, LOC122847302, LOC122847303, LOC122847304, LOC122847305, LOC122847306, LOC122847307, LOC122847308, LOC122847309, LOC122847310, LOC122847311, LOC122847312, LOC122847313, LOC122847314, LOC122847315, LOC122847316, LOC122847317, LOC122847318, LOC122847319, LOC122847320, LOC122861240, LOC122861241, LOC122861242, LOC122861243, LOC122861244, LOC122861245, LOC122861246, LOC126806382, LOC126806383, LOC126806384, LOC126806385, LOC126806386, LOC126806387, LOC126806388, LOC126806389, LOC126806390, LOC126806391, LOC126806392, LOC126806393, LOC126806394, LOC126806395, LOC126806396, LOC126806397, LOC126806398, LOC126806399, LOC126806400, LOC126806401, LOC126806402, LOC126806403, LOC126806404, LOC126806405, LOC126806406, LOC126806407, LOC126806408, LOC126806409, LOC126806410, LOC126806411, LOC126806412, LRP2, LY75, LY75-CD302, MAP3K20, MAP3K20-AS1, MARCHF7, METAP1D, METTL5, METTL8, MIR4774, MIR4785, MIR6888, MIR933, MYO3B, MYO3B-AS1, NOSTRIN, NR4A2, OLA1, PDK1, PHOSPHO2, PHOSPHO2-KLHL23, PKP4, PKP4-AS1, PLA2R1, PPIG, PSMD14, PSMD14-DT, RAPGEF4, RAPGEF4-AS1, RBMS1, SCN1A, SCN1A-AS1, SCN2A, SCN3A, SCN7A, SCN9A, SCRN3
See casesPathogenic
(Mar 10, 2014)
no assertion criteria provided
7.
GRCh37:
Chr2:155223300-167905412
GRCh38:
Chr2:154366788-167048902
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
8.
GRCh37:
Chr2:155363751-158667217
GRCh38:
Chr2:154507239-157810705
Autism spectrum disorderLikely pathogenic
(Oct 12, 2015)
criteria provided, single submitter
9.
GRCh37:
Chr2:158274685-159134033
GRCh38:
Chr2:157418173-158277521
See casesUncertain significance
(Mar 10, 2014)
no assertion criteria provided
10.
GRCh37:
Chr2:158593007
GRCh38:
Chr2:157736495
ACVR1Progressive myositis ossificansUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
11.
GRCh37:
Chr2:158593252
GRCh38:
Chr2:157736740
ACVR1Progressive myositis ossificansBenign
(Jan 13, 2018)
criteria provided, single submitter
12.
GRCh37:
Chr2:158593281
GRCh38:
Chr2:157736769
ACVR1Progressive myositis ossificansBenign
(Jan 13, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr2:158593291
GRCh38:
Chr2:157736779
ACVR1Progressive myositis ossificansUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
14.
GRCh37:
Chr2:158593292
GRCh38:
Chr2:157736780
ACVR1Progressive myositis ossificansUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
15.
GRCh37:
Chr2:158593332
GRCh38:
Chr2:157736820
ACVR1Progressive myositis ossificansUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
16.
GRCh37:
Chr2:158593357
GRCh38:
Chr2:157736845
ACVR1Progressive myositis ossificansBenign
(Jan 13, 2018)
criteria provided, single submitter
17.
GRCh37:
Chr2:158593543
GRCh38:
Chr2:157737031
ACVR1Progressive myositis ossificansUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
18.
GRCh37:
Chr2:158593622
GRCh38:
Chr2:157737110
ACVR1Progressive myositis ossificansUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
19.
GRCh37:
Chr2:158593685
GRCh38:
Chr2:157737173
ACVR1Progressive myositis ossificansBenign
(Jan 13, 2018)
criteria provided, single submitter
20.
GRCh37:
Chr2:158593729
GRCh38:
Chr2:157737217
ACVR1Progressive myositis ossificansUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
21.
GRCh37:
Chr2:158593793
GRCh38:
Chr2:157737281
ACVR1Progressive myositis ossificansUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
22.
GRCh37:
Chr2:158593833
GRCh38:
Chr2:157737321
ACVR1Progressive myositis ossificansUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
23.
GRCh37:
Chr2:158593839-158594128
GRCh38:
Chr2:157737327-157737616
ACVR1P482fsnot providedUncertain significance
(Jul 6, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr2:158593860
GRCh38:
Chr2:157737348
ACVR1Progressive myositis ossificansBenign
(Jan 13, 2018)
criteria provided, single submitter
25.
GRCh37:
Chr2:158593861
GRCh38:
Chr2:157737349
ACVR1Progressive myositis ossificansUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
26.
GRCh37:
Chr2:158593891
GRCh38:
Chr2:157737379
ACVR1Progressive myositis ossificansBenign
(Jan 13, 2018)
criteria provided, single submitter
27.
GRCh37:
Chr2:158593905
GRCh38:
Chr2:157737393
ACVR1not provided, Progressive myositis ossificansBenign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr2:158593906
GRCh38:
Chr2:157737394
ACVR1Progressive myositis ossificansUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
29.
GRCh37:
Chr2:158593996
GRCh38:
Chr2:157737484
ACVR1Progressive myositis ossificansBenign
(Jan 13, 2018)
criteria provided, single submitter
30.
GRCh37:
Chr2:158593998
GRCh38:
Chr2:157737486
ACVR1not provided, Progressive myositis ossificansBenign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr2:158594051-158594052
GRCh38:
Chr2:157737539-157737540
ACVR1D508*not providedUncertain significance
(Oct 23, 2020)
criteria provided, single submitter
32.
GRCh37:
Chr2:158594060
GRCh38:
Chr2:157737548
ACVR1not provided, Progressive myositis ossificansBenign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr2:158594064
GRCh38:
Chr2:157737552
ACVR1not providedLikely benign
(Jul 17, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr2:158594067
GRCh38:
Chr2:157737555
ACVR1not provided, Progressive myositis ossificansBenign
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr2:158594100
GRCh38:
Chr2:157737588
ACVR1not providedLikely benign
(May 29, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr2:158594124
GRCh38:
Chr2:157737612
ACVR1not providedLikely benign
(Nov 1, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr2:158594154
GRCh38:
Chr2:157737642
ACVR1not providedLikely benign
(Aug 8, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr2:158594167
GRCh38:
Chr2:157737655
ACVR1S469Cnot providedUncertain significance
(Feb 3, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr2:158594169
GRCh38:
Chr2:157737657
ACVR1not providedLikely benign
(Oct 25, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr2:158594175
GRCh38:
Chr2:157737663
ACVR1not providedLikely benign
(Oct 24, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr2:158594178-158594179
GRCh38:
Chr2:157737666-157737667
ACVR1Progressive myositis ossificansUncertain significance
(Jan 26, 2023)
criteria provided, single submitter
42.
GRCh37:
Chr2:158594197
GRCh38:
Chr2:157737685
ACVR1not providedLikely benign
(Feb 21, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr2:158594315
GRCh38:
Chr2:157737803
ACVR1not providedBenign
(May 10, 2021)
criteria provided, single submitter
44.
GRCh37:
Chr2:158594408
GRCh38:
Chr2:157737896
ACVR1not providedBenign
(May 10, 2021)
criteria provided, single submitter
45.
GRCh37:
Chr2:158594932
GRCh38:
Chr2:157738420
ACVR1not providedLikely benign
(Apr 4, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr2:158594937
GRCh38:
Chr2:157738425
ACVR1not providedLikely benign
(Oct 10, 2021)
criteria provided, single submitter
47.
GRCh37:
Chr2:158594945
GRCh38:
Chr2:157738433
ACVR1not providedBenign
(May 3, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr2:158594947
GRCh38:
Chr2:157738435
ACVR1Progressive myositis ossificans, not providedLikely benign
(Nov 2, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr2:158594953
GRCh38:
Chr2:157738441
ACVR1P465Lnot provided, Inborn genetic diseasesConflicting interpretations of pathogenicity
(Aug 21, 2022)
criteria provided, conflicting interpretations
50.
GRCh37:
Chr2:158594955
GRCh38:
Chr2:157738443
ACVR1D464Enot providedUncertain significance
(Nov 24, 2015)
criteria provided, single submitter
51.
GRCh37:
Chr2:158594973
GRCh38:
Chr2:157738461
ACVR1not providedLikely benign
(Jul 17, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr2:158594997
GRCh38:
Chr2:157738485
ACVR1not providedLikely benign
(Oct 21, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr2:158594999
GRCh38:
Chr2:157738487
ACVR1V450Mnot providedUncertain significance
(Sep 3, 2021)
criteria provided, single submitter
54.
GRCh37:
Chr2:158595009
GRCh38:
Chr2:157738497
ACVR1K446Nnot providedUncertain significance
(Jun 15, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr2:158595029
GRCh38:
Chr2:157738517
ACVR1S440Gnot providedUncertain significance
(Feb 4, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr2:158595037
GRCh38:
Chr2:157738525
ACVR1N437Snot providedUncertain significance
(Jun 12, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr2:158595039
GRCh38:
Chr2:157738527
ACVR1not providedLikely benign
(Nov 16, 2021)
criteria provided, single submitter
58.
GRCh37:
Chr2:158595050
GRCh38:
Chr2:157738538
ACVR1D433Nnot providedUncertain significance
(Apr 21, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr2:158595051
GRCh38:
Chr2:157738539
ACVR1not providedLikely benign
(Jul 14, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr2:158595057
GRCh38:
Chr2:157738545
ACVR1not providedLikely benign
(Aug 22, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr2:158595089
GRCh38:
Chr2:157738577
ACVR1not providedLikely benign
(Jun 19, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr2:158617373
GRCh38:
Chr2:157760861
ACVR1not providedLikely benign
(Jun 13, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr2:158617403
GRCh38:
Chr2:157760891
ACVR1M418Tnot providedUncertain significance
(Sep 7, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr2:158617414
GRCh38:
Chr2:157760902
ACVR1not providedUncertain significance
(Jul 1, 2017)
criteria provided, single submitter
65.
GRCh37:
Chr2:158617429
GRCh38:
Chr2:157760917
ACVR1not providedLikely benign
(Sep 21, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr2:158617452
GRCh38:
Chr2:157760940
ACVR1V402Inot providedUncertain significance
(Sep 22, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr2:158617458
GRCh38:
Chr2:157760946
ACVR1K400Enot providedUncertain significance
(Feb 24, 2017)
criteria provided, single submitter
68.
GRCh37:
Chr2:158617478
GRCh38:
Chr2:157760966
ACVR1V393Gnot providedUncertain significance
(Apr 1, 2017)
criteria provided, single submitter
69.
GRCh37:
Chr2:158617504
GRCh38:
Chr2:157760992
ACVR1not providedLikely benign
(Oct 23, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr2:158617507
GRCh38:
Chr2:157760995
ACVR1not providedLikely benign
(Jan 4, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr2:158617514
GRCh38:
Chr2:157761002
ACVR1Y381Cnot providedUncertain significance
(Jul 12, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr2:158617525
GRCh38:
Chr2:157761013
ACVR1not provided, Progressive myositis ossificansBenign
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr2:158617530
GRCh38:
Chr2:157761018
ACVR1V376Mnot providedLikely benign
(Jul 5, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr2:158617532
GRCh38:
Chr2:157761020
ACVR1R375PProgressive myositis ossificansPathogenic
(Mar 1, 2009)
no assertion criteria provided
75.
GRCh37:
Chr2:158617547
GRCh38:
Chr2:157761035
ACVR1V370Anot providedLikely benign
(Feb 26, 2018)
criteria provided, single submitter
76.
GRCh37:
Chr2:158617570
GRCh38:
Chr2:157761058
ACVR1not provided, Progressive myositis ossificansBenign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr2:158617576
GRCh38:
Chr2:157761064
ACVR1M360Inot providedUncertain significance
(Dec 27, 2021)
criteria provided, single submitter
78.
GRCh37:
Chr2:158617583
GRCh38:
Chr2:157761071
ACVR1A358EProgressive myositis ossificansUncertain significance
(Feb 18, 2020)
criteria provided, single submitter
79.
GRCh37:
Chr2:158617589
GRCh38:
Chr2:157761077
ACVR1G356Dnot provided, Progressive myositis ossificansPathogenic
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr2:158617602
GRCh38:
Chr2:157761090
ACVR1not providedLikely benign
(May 16, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr2:158617814
GRCh38:
Chr2:157761302
ACVR1not providedBenign
(Jun 18, 2021)
criteria provided, single submitter
82.
GRCh37:
Chr2:158622416
GRCh38:
Chr2:157765904
ACVR1not providedLikely benign
(Oct 18, 2021)
criteria provided, single submitter
83.
GRCh37:
Chr2:158622461
GRCh38:
Chr2:157765949
ACVR1K346Nnot providedUncertain significance
(Sep 24, 2021)
criteria provided, single submitter
84.
GRCh37:
Chr2:158622470
GRCh38:
Chr2:157765958
ACVR1Progressive myositis ossificansUncertain significance
(Apr 28, 2017)
criteria provided, single submitter
85.
GRCh37:
Chr2:158622481
GRCh38:
Chr2:157765969
ACVR1K340Enot providedUncertain significance
(Jun 8, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr2:158622511
GRCh38:
Chr2:157765999
ACVR1P330AInborn genetic diseasesUncertain significance
(Sep 7, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr2:158622511
GRCh38:
Chr2:157765999
ACVR1P330Snot providedUncertain significance
(Feb 9, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr2:158622516
GRCh38:
Chr2:157766004
ACVR1G328VDiffuse intrinsic pontine gliomaothercriteria provided, single submitter
89.
GRCh37:
Chr2:158622516
GRCh38:
Chr2:157766004
ACVR1G328EInborn genetic diseases, Progressive myositis ossificansPathogenic/Likely pathogenic
(Oct 12, 2018)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr2:158622517
GRCh38:
Chr2:157766005
ACVR1G328WProgressive myositis ossificansPathogenic
(Mar 1, 2009)
no assertion criteria provided
91.
GRCh37:
Chr2:158622517
GRCh38:
Chr2:157766005
ACVR1G328RProgressive myositis ossificansPathogenic
(Mar 1, 2009)
no assertion criteria provided
92.
GRCh37:
Chr2:158622542
GRCh38:
Chr2:157766030
ACVR1not providedLikely benign
(Sep 26, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr2:158622579
GRCh38:
Chr2:157766067
ACVR1R307Qnot provided, Inborn genetic diseasesUncertain significance
(Jul 12, 2022)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr2:158622605
GRCh38:
Chr2:157766093
ACVR1not providedLikely benign
(Sep 4, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr2:158622620
GRCh38:
Chr2:157766108
ACVR1not providedLikely benign
(Jul 12, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr2:158622623
GRCh38:
Chr2:157766111
ACVR1not providedLikely benign
(Jun 25, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr2:158622629
GRCh38:
Chr2:157766117
ACVR1not providedBenign
(Jul 18, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr2:158622635
GRCh38:
Chr2:157766123
ACVR1M288Inot providedUncertain significance
(Sep 27, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr2:158622679
GRCh38:
Chr2:157766167
ACVR1H274YProgressive myositis ossificansUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
100.
GRCh37:
Chr2:158626861
GRCh38:
Chr2:157770349
ACVR1not providedLikely benign
(Apr 8, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination